CCL2 and neoplasm: Although various targets have been explored to reprogram or deplete tumor-associated macrophages, inhibition of the colony stimulating factor 1 (CSF1) or C-C Motif Chemokine Ligand 2 (CCL2) signaling have been particularly reported [97,98].